Stay updated on 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.

Latest updates to the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 was added. Related topics were removed from the related topics list.SummaryDifference0.2%

- Check13 days agoChange DetectedAdded related topic 'Multiple myeloma' and linked 'MedlinePlus Genetics' under related topics.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe related topics section now excludes 'Multiple myeloma' and 'MedlinePlus Genetics' from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedRevision: v3.4.2 is now displayed; prior notices about government funding and operating status were removed.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a site-wide funding notice about government funding lapses and an operating status update. Included a related topic tag for Multiple myeloma and updated the revision history to v3.4.1 while removing v3.4.0.SummaryDifference0.6%

- Check48 days agoChange DetectedThe page now shows a glossary and adds the 'Last Update Submitted that Met QC Criteria' indicator, plus a revision note 'Revision: v3.4.0'. It also removes certain related topics and older QC labels such as 'MedlinePlus Genetics', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.4%

Stay in the know with updates to 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.